House Republican leaders propose a healthcare bill to extend ACA subsidies, reduce premiums for low-income individuals, and increase prescription drug price transparency amid rising insurance costs.

The U.S. federal government has paid $16 billion to Medicare Part D insurers due to rising prescription drug spending, highlighting cost and risk management challenges in Medicare drug plans.

Pharmaceutical companies agree to reduce Medicare prices for 15 prescription drugs, potentially saving billions in taxpayer and patient costs under new negotiation rules starting in 2027.

The HELP Copays Act aims to reduce prescription drug costs by ensuring copay assistance counts toward patients' deductibles and out-of-pocket limits, promoting insurance transparency and affordability.

Medicare Part D stand-alone drug plans decline as enrollment in Medicare Advantage with drug coverage rises, reshaping market options for 2026.

CMS reveals new 2027 price caps for 15 Medicare Part D drugs, projected to save billions federally and reduce patient costs under the Inflation Reduction Act negotiations.

Learn how to avoid costly Medicare enrollment mistakes by understanding coverage options, enrollment deadlines, and supplemental plans like Medigap and Medicare Advantage. Optimize healthcare costs with annual plan reviews and proper prescription drug coverage enrollment.

Understand Medicare Part D enrollment deadlines, costs, coverage tiers, and out-of-pocket caps for seniors. Learn how to avoid penalties and manage prescription drug expenses effectively.

The Increasing Medication Access for Seniors Act of 2025 proposes interest-free monthly payments for costly Medicare prescriptions, improving affordability and transparency in the Medicare Prescription Payment Plan.

Medicare open enrollment runs through Dec. 7, 2025. Learn about key 2026 changes in Medicare Advantage and Part D plans, prescription drug costs, premium adjustments, and cost-saving programs.